Hypervolemia, hypoalbuminemia and mitral calcification as markers of cardiovascular risk in peritoneal dialysis patients | Zendy

Sara Querido | Zendy; Patrícia Branco | Zendy; Henrique Sousa | Zendy; Teresa Adragão | Zendy; Pedro de Araújo Gonçalves | Zendy; Maria Augusta Gaspar | Zendy; José Diogo Barata | Zendy

Open Access

Hypervolemia, hypoalbuminemia and mitral calcification as markers of cardiovascular risk in peritoneal dialysis patients

Author(s) -

Sara Querido,

Patrícia Branco,

Henrique Sousa,

Teresa Adragão,

Pedro de Araújo Gonçalves,

Maria Augusta Gaspar,

José Diogo Barata

Publication year - 2017

Publication title -

revista portuguesa de cardiologia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.266

H-Index - 26

eISSN - 2174-2030

pISSN - 0870-2551

DOI - 10.1016/j.repc.2016.12.014

Subject(s) - medicine , hypervolemia , hypoalbuminemia , peritoneal dialysis , cardiology , end stage renal disease , dialysis , population , surgery , hemodialysis , blood volume , environmental health

Mortality in patients with end-stage renal disease is higher than in the general population. This is linked to traditional and non-traditional cardiovascular (CV) risk factors, as well as with risk factors associated with end-stage renal disease itself. The aim of this study is to identify CV risk markers in patients beginning peritoneal dialysis (PD) and their association with CV events and CV mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research